SCHEMBL2553280

SCHEMBL2553280

CNC(=O)c1cccc(-n2c(C(CN)C(C)=O)nc3ccc(F)cc32)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 4/20 0.41
PIK3R1 P27986 4/20 0.41
PIK3CG P48736 4/20 0.41
PIK3CA P42336 3/20 0.41
PIK3CB P42338 3/20 0.41
HPGD P15428 2/20 0.41
MAPK14 Q16539 1/20 0.40
ACSS2 Q9NR19 4/20 0.40
LMNA P02545 1/20 0.39
PTGER1 P34995 1/20 0.38
SLC7A5 Q01650 1/20 0.36
MAPT P10636 1/20 0.36
SCN9A Q15858 1/20 0.36
GAA P10253 1/20 0.36
CRBN Q96SW2 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2506959 0.86 PIK3CD (0.45) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL2505253 0.83 ALDH1A1 (0.46) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL12264216 0.76 PIK3CD (0.63) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL2505569 0.74 PIK3CD (0.79) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL2507120 0.74 PIK3CD (0.79) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL2504026 0.74 PIK3CD (0.79) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL2504398 0.71 PIK3CD (0.55) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL13495586 0.70 PIK3CA (0.60) PIK3CDPIK3CAHPGDMAPK14ACSS2
SCHEMBL12264214 0.69 PIK3CD (0.55) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB
SCHEMBL11901900 0.69 PIK3CD (0.53) PIK3CDPIK3R1PIK3CGPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2552908-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2013-02-06 EP disclosed
WO-2011123751-A2 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2011-10-06 WO disclosed